NI
Novavax Inc
🇩🇪XFRA.NVV1GermanyHealthcare
€8.12EURup +0.14 (+1.75%)ClosedEnd of day1:01 AM
Price€8.12+0.14 (+1.75%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US6700024010
- CUSIP
- Not reported
Company
- Employees
- 749
- Headquarters
- Gaithersburg, United States
- Website
- https://www.novavax.com
- CEO
- Mr. John Charles Jacobs M.B.A.
Market
- Shares outstanding
- 164.9M
- Market cap
- €1.34B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- €1.32B
- EPS LTM
- -$1.50calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $413.8M-61.64%down year on year
- Net income
- -$247.73M-158.59%down year on year
- Gross margin
- 77.85%-11.88%down year on year
- Free cash flow
- -$43.59M+93.16%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.